Decreased expression of Annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression

Oncology Reports

Volumn 24, Issue 3, 2010, Pages 607-612

  Kim, Jeong Kyu ^a   Kim, Pum Joon ^b   Jung, Kwang Hwa ^a   Noh, Ji Heon ^a   Eun, Jung Woo ^a   Bae, Hyun Jin ^a   Xie, Hong Jian ^a   Shan, Jin Mei ^c   Ping, Wang Ying ^c   Park, Won Sang ^a   Lee, Jung Young ^a   Nam, Suk Woo ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Annexin A10; Apoptosis; Calcium binding protein; Cell growth; Gastric carcinoma

Indexed keywords

ANNEXIN; ANNEXIN A10; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; WESTERN BLOTTING;

EID: 77956304668     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000898     Document Type: Article

References (37)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841, 1999.
2. Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA Cancer J Clin 49: 33-64, 1999.
3. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
4. Kinzler KW and Vogelstein B: Life (and death) in a malignant tumour. Nature 379: 19-20, 1996.
5. Park WS, Lee JH, Shin MS, et al: Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 21: 2919-2925, 2002.
6. Park WS, Oh RR, Park JY, et al: Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119: 691-698, 2000.
7. Werner M, Becker KF, Keller G and Hofler H: Gastric adenocarcinoma: Pathomorphology and molecular pathology. J Cancer Res Clin Oncol 127: 207-216, 2001. (Pubitemid 32250062)
8. Fuchs CS and Mayer RJ: Gastric carcinoma. N Engl J Med 333: 32-41, 1995.
9. Sano T, Tsujino T, Yoshida K, et al: Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 51: 2926-2931, 1991.
10. Uchino S, Tsuda H, Noguchi M, et al: Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52: 3099-3102, 1992.
11. Semba S, Yokozaki H, Yasui W and Tahara E: Frequent micro-satellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer. Int J Oncol 12: 1245-1251, 1998.
12. Wang Y, Zheng E and Ke Y: Studies of loss of heterozygosity (LOH) in chinese human gastric cancer tissues. Zhonghua Zhong Liu Za Zhi 20: 116-118, 1998.
13. Kim J, Kim MA, Jee CD, Jung EJ and Kim WH: Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma. Int J Cancer 125: 1842-1850, 2009.
14. 2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461, 2005.
15. Hayes MJ and Moss SE: Annexins and disease. Biochem Biophys Res Commun 322: 1166-1170, 2004.
16. Gerke V and Moss SE: Annexins: from structure to function. Physiol Rev 82: 331-371, 2002.
17. Hayes MJ, Longbottom RE, Evans MA and Moss SE: Annexinopathies. Subcell Biochem 45: 1-28, 2007.
18. Rand JH: The annexinopathies: A new category of diseases. Biochim Biophys Acta 1498: 169-173, 2000.
19. Rescher U and Gerke V: Annexins - unique membrane binding proteins with diverse functions. J Cell Sci 117: 2631-2639, 2004. (Pubitemid 38997247)
20. Mussunoor S and Murray GI: The role of annexins in tumour development and progression. J Pathol 216: 131-140, 2008.
21. Liu SH, Lin CY, Peng SY, et al: Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol 160: 1831-1837, 2002.
22. Kononen J, Bubendorf L, Kallioniemi A, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847, 1998.
23. Smith PD and Moss SE: Structural evolution of the annexin supergene family. Trends Genet 10: 241-246, 1994.
24. Dubois T, Oudinet JP, Mira JP and Russo-Marie F: Annexins and protein kinases C. Biochim Biophys Acta 1313: 290-294, 1996.
25. Benz J and Hofmann A: Annexins: from structure to function. Biol Chem 378: 177-183, 1997.
26. Raynal P and Pollard HB: Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197: 63-93, 1994. (Pubitemid 124002008)
27. Morgan RO and Fernandez MP: Annexin gene structures and molecular evolutionary genetics. Cell Mol Life Sci 53: 508-515, 1997. (Pubitemid 27374491)
28. Srivastava M, Bubendorf L, Srikantan V, et al: ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci USA 98: 4575-4580, 2001.
29. Garcia Pedrero JM, Fernandez MP, Morgan RO, et al: Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 164: 73-79, 2004.
30. Morgan RO, Jenkins NA, Gilbert DJ, et al: Novel human and mouse annexin A10 are linked to the genome duplications during early chordate evolution. Genomics 60: 40-49, 1999.
31. Deloukas P, Schuler GD, Gyapay G, et al: A physical map of 30,000 human genes. Science 282: 744-746, 1998.
32. Yeh SH, Chen PJ, Lai MY and Chen DS: Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: Association with elevated alpha-fetoprotein production. Gastroenterology 110: 184-192, 1996.
33. Nagai H, Pineau P, Tiollais P, Buendia MA and Dejean A: Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 14: 2927-2933, 1997.
34. Bando K, Nagai H, Matsumoto S, et al: Identification of a 1-cM region of common deletion on 4q35 associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer 25: 284-289, 1999. (Pubitemid 29266698)
35. Wong N, Lai P, Lee SW, et al: Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: Relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 154: 37-43, 1999.
36. Matsubara D, Niki T, Ishikawa S, et al: Differential expression of S100A2 and S100A4 in lung adenocarcinomas: Clinicopathological significance, relationship to p53 and identification of their target genes. Cancer Sci 96: 844-857, 2005.
37. Koh KH, Rhee H, Kang HJ, et al: Differential gene expression profiles of metastases in paired primary and metastatic colorectal carcinomas. Oncology 75: 92-101, 2008.